{"id":155333,"date":"2017-10-25T14:00:04","date_gmt":"2017-10-25T14:00:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=155333"},"modified":"2017-10-25T14:00:04","modified_gmt":"2017-10-25T14:00:04","slug":"improved-chromatin-immunoprecipitation-chip-assay-service-released-in-profacgen","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/improved-chromatin-immunoprecipitation-chip-assay-service-released-in-profacgen_155333.html","title":{"rendered":"Improved Chromatin Immunoprecipitation (ChIP) Assay Service Released in Profacgen"},"content":{"rendered":"
\"\"<\/a><\/div>\n

Profacgen has introduced an improved version of its popular Chromatin Immunoprecipitation<\/a> (ChIP) Assay Service to help map DNA binding sites for proteins of interest on a genome-wide scale.<\/p>\n

Chromatin Immunoprecipitaion is a technique commonly used for mapping DNA-protein interactions in cells. With the development of NGS, the combination of CHIP and NGS, Chromatin Immunoprecipitation Sequencing (ChIP-Seq<\/a>), is now able to screen and identify the protein binding sites on the entire chromosomal scale with high efficiency and accuracy.<\/p>\n

As a professional ChIP service provider that offers comprehensive ChIP solutions, Profacgen provides services from protein-DNA complex fixation, chromatin digestion, protein-DNA complex immunoprecipitation, high-throughput sequencing to data analysis.<\/p>\n

“Our optimized reagents and protocol guarantees minimal background with increased sensitivity and specificity. Moreover, QC is included in each critical step to ensure accuracy. As one of the most popular services, ChIP service in the past few years has helped increasing number of scientists in this field. At the threshold of this enhancement, we do hope our customers can enjoy a better service.” Commented Crystal, representative from Profacgen.<\/p>\n

To know more about ChIP service in Profacgen, please visit https:\/\/www.profacgen.com\/chromatin-immunoprecipitation-chip-assay-service.htm<\/a>.<\/p>\n

About Profacgen<\/strong><\/p>\n

Profacgen<\/a> provides process development and cGMP manufacturing services for biological active ingredients. We have ready access to state-of-the-art biopharmaceutical product development and manufacturing facilities and our staff scientists have demonstrable expertise in all aspects of biopharmaceutical manufacturing, from facility design and operation to the ability to provide best advice relating to product development. We also save our clients a great deal of time with bioprocess scale-up services. Our fermentation laboratories are equipped with state-of-the-art fermentors and bioreactors that enable us to express protein in large scale. Our customers can choose to enter into the protein expression pipeline at any stage depending on their needs.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Profacgen
Contact Person:<\/strong> Ellen Burns
Email:<\/strong> info@profacgen.com
Phone:<\/strong> 1-631-448-8149
Address:<\/strong>45-1 Ramsey Road
City:<\/strong> Shirley
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> www.profacgen.com\/<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Profacgen has introduced an improved version of its popular Chromatin Immunoprecipitation (ChIP) Assay Service to help map DNA binding sites for proteins of interest on a genome-wide scale. Chromatin Immunoprecipitaion is a technique commonly used for mapping DNA-protein interactions in … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-155333","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/155333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=155333"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/155333\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=155333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=155333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=155333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}